Abstract Library

#3715 Finding the frequency of bronchial carcinoid tumors associated with neuroendocrine syndrome

Introduction: Pulmonary carcinoid tumors are part of bronchopulmonary neuroendocrine neoplasms (bpNETs) along with large and small cell pulmonary carcinoma. They are capable of producing a variety of peptides and biological active hormones such as serotonin, histamine, bombesin thus leading to several endocrine syndromes.

Conference:

Presenting Author:

Authors: Fatima A,

Keywords: bronchial carcinoid, pulmonary carcinoma, carcinoid syndrome,

#3186 Bronchopulmonary neuroendocrine tumors (bpNET) - A comparison of three subgroups

Introduction: bpNET are a rare malignancy of the lung, that arise sporadically (sp-bpNET), in the context of Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome, or in the context of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH). Until now, bpNET of any type are regarded as similar entities. Clinically however, bpNET within MEN1 or DIPNECH rarely metastasize or lead to bpNET related death.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Levy S

Authors: Levy S, van den Broek M, Dijke K, Hartemink K, van Leeuwaarde R,

Keywords: bpNET, MEN1, DIPNECH,

#2220 Validation of a Blood-Based Biomarker Test for the Diagnosis and Management of Bronchopulmonary Neuroendocrine Tumors

Introduction: There is currently no effective blood biomarker for lung neuroendocrine neoplasia diagnosis and management.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Modlin I

Authors: Modlin I, Kidd M, Lewczuk-Myślińska A, Chung K, Ćwikła J,

Keywords: bronchopulmonary, lung, biomarker, PCR, diagnostics, progression,

#1883 Utility of a Circulating NET mRNA Gene Signature for Defining Bronchopulmonary Neuroendocrine Neoplasia and Evaluating Disease Progression

Introduction: Bronchopulmonary NETs (BPNETs) exhibit indolent to aggressive behavior. Imaging, histology and biochemistry are limited in accurately defining malignancy or progression. A blood based NET multigene test is effective in diagnosing GEP-NET progression and therapy response.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Kidd M

Authors: Lewczuk A, Chung K, Kolasińska-Ćwikła A, Ćwikła J, Kidd M,

Keywords: NET,

#1571 Blood Gene Transcript Analysis Diagnoses Bronchopulmonary NETs and Identifies Progressive Disease

Introduction: Broncho-Pulmonary (BP) NETs are pulmonary neoplasms with indolent to aggressive behavior. Imaging, histology and biochemistry are limited in defining malignancy or progression

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Lewczuk A

Authors: Lewczuk A, Chung K, Kolasińska-Ćwikła A, Cwikła J, Kidd M,

Keywords: PCR,